Skip to Main Content

Paper Details

Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings.
Am J Transplant
51
2017
Author NameAffiliation
Stephen R WisniewskiGraduate School of Public Health, University of Pittsburgh
  • 1 - 1

Datasets

Release 1.2